National Health Investors (NYSE:NHI – Get Free Report) released its earnings results on Tuesday. The real estate investment trust reported $1.13 EPS for the quarter, topping analysts’ consensus estimates of $1.10 by $0.03, Zacks reports. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. National Health Investors updated its FY 2025 guidance to 4.590-4.660 EPS.
National Health Investors Stock Performance
Shares of NYSE NHI opened at $71.35 on Wednesday. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92. National Health Investors has a 12 month low of $56.70 and a 12 month high of $86.13. The company has a 50 day simple moving average of $68.59 and a two-hundred day simple moving average of $75.08. The stock has a market cap of $3.24 billion, a price-to-earnings ratio of 24.52, a PEG ratio of 4.42 and a beta of 1.06.
Wall Street Analyst Weigh In
Separately, Truist Financial lowered their target price on shares of National Health Investors from $78.00 to $72.00 and set a “hold” rating for the company in a research note on Monday, December 23rd. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $76.60.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
See Also
- Five stocks we like better than National Health Investors
- Upcoming IPO Stock Lockup Period, Explained
- Viking Therapeutics: Could GLP-1 Maker Be Acquired Pre-Approval?
- Short Selling – The Pros and Cons
- 3 Industry Leading Stocks Just Raised Dividends by 10% or More
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Twilio, Braze: The Top 2 CEP Platforms to Own in 2025
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.